孕期、分娩期及新生儿期的血浆前激肽释放酶和激肽释放酶抑制剂
Plasmatic prekallikrein and kallikrein inhibitor in pregnancy, labor and in newborn.
作者信息
Branconi F, Faldi P, Seravalli G, Curradi C, Del Bianco P L, Sicuteri F
出版信息
Adv Exp Med Biol. 1976;70(00):261-3. doi: 10.1007/978-1-4684-3267-1_31.
In order to reveal the possible physiological role of the kallikrein during the stress of birth, the prekallikrein and kallikrein inhibitor were evaluated in 15 pregnant women and in 15 newborns from terminated pregnancies. The results show a very low level of prekallikrein in the funiculus blood at the moment of birth and a still lower level in venous blood 24 hours after birth. No important changes resulted in the mother's blood either in pregnancy, nor at the end of the labour.
为了揭示激肽释放酶在分娩应激过程中可能的生理作用，对15名孕妇以及15名终止妊娠的新生儿的前激肽释放酶和激肽释放酶抑制剂进行了评估。结果显示，出生时脐带血中的前激肽释放酶水平极低，出生24小时后静脉血中的水平更低。母亲的血液在孕期以及分娩结束时均未出现显著变化。
Zotero 插件